Iovance Biotherapeutics (IOVA) Accumulated Expenses (2013 - 2026)
Iovance Biotherapeutics (IOVA) posted Accumulated Expenses of $77.96 million for Q2 2026, down 12.5% from $89.08 million a year earlier and down 11.5% from the prior quarter.
Iovance Biotherapeutics (IOVA) Accumulated Expenses (2013 - 2026) Analysis & Trends
At the end of FY2025, Iovance Biotherapeutics' Accumulated Expenses came in at $111.16 million, up 35.7% from FY2024.
- Annual Accumulated Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
- In prior years, Iovance Biotherapeutics' Accumulated Expenses was $81.94 million in FY2024 (+18.1%), $69.41 million in FY2023 (+32.7%), $52.3 million in FY2022 (-7.9%) and $56.77 million in FY2021 (+61.8%).
- The Q2 2026 figure stands as the lowest quarterly Accumulated Expenses since Q1 2024.
- On a year-over-year basis, Accumulated Expenses increased in four of the last five quarters, with growth averaging 25.5%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2025, with growth of 82.4%; the weakest was Q2 2026, with a decline of 12.5%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $88.07 million (Q1 2026), $111.16 million (Q4 2025) and $87.27 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.96 Mn |
| Mar 31, 2026 | 88.07 Mn |
| Dec 31, 2025 | 111.16 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Jun 30, 2025 | 89.08 Mn |
| Mar 31, 2025 | 84.71 Mn |
| Dec 31, 2024 | 81.94 Mn |
| Mar 31, 2024 | 46.44 Mn |
| Dec 31, 2023 | 69.41 Mn |
| Sep 30, 2023 | 61.21 Mn |
| Jun 30, 2023 | 46.62 Mn |
| Mar 31, 2023 | 43.09 Mn |
| Dec 31, 2022 | 52.30 Mn |
| Sep 30, 2022 | 47.82 Mn |
| Jun 30, 2022 | 37.70 Mn |
| Mar 31, 2022 | 48.91 Mn |
| Dec 31, 2021 | 56.77 Mn |
| Sep 30, 2021 | 45.97 Mn |
| Jun 30, 2021 | 34.19 Mn |
| Mar 31, 2021 | 35.77 Mn |
Iovance Biotherapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();